LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹8.52 Cr | ₹6.59 Cr | ₹3.32 Cr | ₹3.16 Cr | ₹0.53 Cr |
What is the latest Contingent Liabilities ratio of LACTOSE (INDIA) ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹8.52 Cr |
Mar2023 | ₹6.59 Cr |
Mar2022 | ₹3.32 Cr |
Mar2021 | ₹3.16 Cr |
Mar2020 | ₹0.53 Cr |
How is Contingent Liabilities of LACTOSE (INDIA) Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹8.52 Cr | 29.32 | |
Mar2023 | ₹6.59 Cr | 98.58 | |
Mar2022 | ₹3.32 Cr | 4.93 | |
Mar2021 | ₹3.16 Cr | 501.14 | |
Mar2020 | ₹0.53 Cr | - |
Compare Contingent Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹251.7 Cr | -1.8% | -8.9% | 30% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -1.8% |
-8.9% |
30% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses